Dartmouth Tuberculosis Vaccine Passes an Important Milestone

Mother touching noses with baby

Investigators at the Geisel School of Medicine have announced that two new studies of DAR-901, their investigational vaccine against tuberculosis, have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.

“We are very pleased with the results of these two studies,” says C. Fordham von Reyn ’67, a professor of medicine at Geisel and the principal investigator for the DAR-901 booster vaccine. “They represent major milestones on the path to approval of DAR‑901 and the global fight against tuberculosis.”

Von Reyn is among nine people who will be awarded honorary degrees at Dartmouth’s commencement ceremony on June 11.

READ MORE AT: https://news.dartmouth.edu/news/2017/05/dartmouth-tuberculosis-vaccine-passes-important-milestone

Share this article:

SUBSCRIBE

You’ve got questions. That’s a good thing.

As parents, determining how best to protect our children can be overwhelming and confusing. We’re here to help.

Related Stories

About I Vaccinate

I Vaccinate provides information and tools based on real medical science and research to help Michigan parents protect their kids. Support is provided by the Michigan Department of Health and Human Services and the Franny Strong Foundation.

You’ve got questions. That’s a good thing.

As parents, determining how best to protect our children can be overwhelming and confusing. We’re here to help.

©2025 Franny Strong Foundation | All rights reserved

Add Your Heading Text Here